 | • レポートコード：D0GIR-02678 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、IBS治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。IBS治療の種類別市場規模（IBS-D、IBS-C、IBS-M）、用途別市場規模（病院、クリニック、研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Allergan Plc (Ireland)、Ardelyx, Inc. (U.S.)、Astellas Pharma Inc. (Japan)、Sucampo Pharmaceuticals (U.S.)、Synergy Pharmaceuticals, Inc. (U.S.)、Ironwood Pharmaceuticals, Inc. (U.S.)、Sebela Pharmaceuticals (Ireland)、Abbott Laboratories (U.S.)、Bausch Health、Nestle (Switzerland)、Ipsen (France)、Synthetic Biologics, Inc. (U.S.)、Probi (Sweden)、Pfizer Inc (U.S.)、Novartis AG (Switzerland)、AstraZeneca (U.K)、Alfasigma USA, Inc. (Italy)、Protagonist Therapeutics Inc. (U.S.)、Takeda Pharmaceutical Company Ltd (Japan)、RedHill Biopharma Ltd. (Israel)、Lexicon Pharmaceuticals, Inc. (U.S.)、Innovate Biopharmaceuticals (U.S.) ・地域別グローバル市場分析 2015年-2020年 ・IBS治療の北米市場（アメリカ、カナダ、メキシコ） ・IBS治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・IBS治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・IBS治療の南米市場（ブラジル、アルゼンチン） ・IBS治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：IBS-D、IBS-C、IBS-M ・用途別分析：病院、クリニック、研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global IBS Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The IBS Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
IBS Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, IBS Treatment market has been segmented into:
IBS-D
IBS-C
IBS-M
By Application, IBS Treatment has been segmented into:
Hospitals
Clinics
Research Laboratories
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global IBS Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level IBS Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global IBS Treatment market.
The report offers in-depth assessment of the growth and other aspects of the IBS Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and IBS Treatment Market Share Analysis
IBS Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, IBS Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the IBS Treatment sales, revenue and market share for each player covered in this report.
The major players covered in IBS Treatment are:
Allergan Plc (Ireland)
Ardelyx, Inc. (U.S.)
Astellas Pharma Inc. (Japan)
Sucampo Pharmaceuticals (U.S.)
Synergy Pharmaceuticals, Inc. (U.S.)
Ironwood Pharmaceuticals, Inc. (U.S.)
Sebela Pharmaceuticals (Ireland)
Abbott Laboratories (U.S.)
Bausch Health
Nestle (Switzerland)
Ipsen (France)
Synthetic Biologics, Inc. (U.S.)
Probi (Sweden)
Pfizer Inc (U.S.)
Novartis AG (Switzerland)
AstraZeneca (U.K)
Alfasigma USA, Inc. (Italy)
Protagonist Therapeutics Inc. (U.S.)
Takeda Pharmaceutical Company Ltd (Japan)
RedHill Biopharma Ltd. (Israel)
Lexicon Pharmaceuticals, Inc. (U.S.)
Innovate Biopharmaceuticals (U.S.)
Table of Contents
1 IBS Treatment Market Overview
1.1 Product Overview and Scope of IBS Treatment
1.2 Classification of IBS Treatment by Type
1.2.1 Global IBS Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global IBS Treatment Revenue Market Share by Type in 2019
1.2.3 IBS-D
1.2.4 IBS-C
1.2.5 IBS-M
1.3 Global IBS Treatment Market by Application
1.3.1 Overview: Global IBS Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Laboratories
1.4 Global IBS Treatment Market by Regions
1.4.1 Global IBS Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of IBS Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) IBS Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) IBS Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) IBS Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) IBS Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) IBS Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan Plc (Ireland)
2.1.1 Allergan Plc (Ireland) Details
2.1.2 Allergan Plc (Ireland) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan Plc (Ireland) SWOT Analysis
2.1.4 Allergan Plc (Ireland) Product and Services
2.1.5 Allergan Plc (Ireland) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ardelyx, Inc. (U.S.)
2.2.1 Ardelyx, Inc. (U.S.) Details
2.2.2 Ardelyx, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ardelyx, Inc. (U.S.) SWOT Analysis
2.2.4 Ardelyx, Inc. (U.S.) Product and Services
2.2.5 Ardelyx, Inc. (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astellas Pharma Inc. (Japan)
2.3.1 Astellas Pharma Inc. (Japan) Details
2.3.2 Astellas Pharma Inc. (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astellas Pharma Inc. (Japan) SWOT Analysis
2.3.4 Astellas Pharma Inc. (Japan) Product and Services
2.3.5 Astellas Pharma Inc. (Japan) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sucampo Pharmaceuticals (U.S.)
2.4.1 Sucampo Pharmaceuticals (U.S.) Details
2.4.2 Sucampo Pharmaceuticals (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sucampo Pharmaceuticals (U.S.) SWOT Analysis
2.4.4 Sucampo Pharmaceuticals (U.S.) Product and Services
2.4.5 Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Synergy Pharmaceuticals, Inc. (U.S.)
2.5.1 Synergy Pharmaceuticals, Inc. (U.S.) Details
2.5.2 Synergy Pharmaceuticals, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Synergy Pharmaceuticals, Inc. (U.S.) SWOT Analysis
2.5.4 Synergy Pharmaceuticals, Inc. (U.S.) Product and Services
2.5.5 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Ironwood Pharmaceuticals, Inc. (U.S.)
2.6.1 Ironwood Pharmaceuticals, Inc. (U.S.) Details
2.6.2 Ironwood Pharmaceuticals, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Ironwood Pharmaceuticals, Inc. (U.S.) SWOT Analysis
2.6.4 Ironwood Pharmaceuticals, Inc. (U.S.) Product and Services
2.6.5 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sebela Pharmaceuticals (Ireland)
2.7.1 Sebela Pharmaceuticals (Ireland) Details
2.7.2 Sebela Pharmaceuticals (Ireland) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sebela Pharmaceuticals (Ireland) SWOT Analysis
2.7.4 Sebela Pharmaceuticals (Ireland) Product and Services
2.7.5 Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott Laboratories (U.S.)
2.8.1 Abbott Laboratories (U.S.) Details
2.8.2 Abbott Laboratories (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abbott Laboratories (U.S.) SWOT Analysis
2.8.4 Abbott Laboratories (U.S.) Product and Services
2.8.5 Abbott Laboratories (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bausch Health
2.9.1 Bausch Health Details
2.9.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bausch Health SWOT Analysis
2.9.4 Bausch Health Product and Services
2.9.5 Bausch Health IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Nestle (Switzerland)
2.10.1 Nestle (Switzerland) Details
2.10.2 Nestle (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Nestle (Switzerland) SWOT Analysis
2.10.4 Nestle (Switzerland) Product and Services
2.10.5 Nestle (Switzerland) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ipsen (France)
2.11.1 Ipsen (France) Details
2.11.2 Ipsen (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ipsen (France) SWOT Analysis
2.11.4 Ipsen (France) Product and Services
2.11.5 Ipsen (France) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Synthetic Biologics, Inc. (U.S.)
2.12.1 Synthetic Biologics, Inc. (U.S.) Details
2.12.2 Synthetic Biologics, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Synthetic Biologics, Inc. (U.S.) SWOT Analysis
2.12.4 Synthetic Biologics, Inc. (U.S.) Product and Services
2.12.5 Synthetic Biologics, Inc. (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Probi (Sweden)
2.13.1 Probi (Sweden) Details
2.13.2 Probi (Sweden) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Probi (Sweden) SWOT Analysis
2.13.4 Probi (Sweden) Product and Services
2.13.5 Probi (Sweden) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Pfizer Inc (U.S.)
2.14.1 Pfizer Inc (U.S.) Details
2.14.2 Pfizer Inc (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Pfizer Inc (U.S.) SWOT Analysis
2.14.4 Pfizer Inc (U.S.) Product and Services
2.14.5 Pfizer Inc (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novartis AG (Switzerland)
2.15.1 Novartis AG (Switzerland) Details
2.15.2 Novartis AG (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novartis AG (Switzerland) SWOT Analysis
2.15.4 Novartis AG (Switzerland) Product and Services
2.15.5 Novartis AG (Switzerland) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 AstraZeneca (U.K)
2.16.1 AstraZeneca (U.K) Details
2.16.2 AstraZeneca (U.K) Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 AstraZeneca (U.K) SWOT Analysis
2.16.4 AstraZeneca (U.K) Product and Services
2.16.5 AstraZeneca (U.K) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Alfasigma USA, Inc. (Italy)
2.17.1 Alfasigma USA, Inc. (Italy) Details
2.17.2 Alfasigma USA, Inc. (Italy) Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Alfasigma USA, Inc. (Italy) SWOT Analysis
2.17.4 Alfasigma USA, Inc. (Italy) Product and Services
2.17.5 Alfasigma USA, Inc. (Italy) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Protagonist Therapeutics Inc. (U.S.)
2.18.1 Protagonist Therapeutics Inc. (U.S.) Details
2.18.2 Protagonist Therapeutics Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Protagonist Therapeutics Inc. (U.S.) SWOT Analysis
2.18.4 Protagonist Therapeutics Inc. (U.S.) Product and Services
2.18.3 Protagonist Therapeutics Inc. (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 Takeda Pharmaceutical Company Ltd (Japan)
2.19.1 Takeda Pharmaceutical Company Ltd (Japan) Details
2.19.2 Takeda Pharmaceutical Company Ltd (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Takeda Pharmaceutical Company Ltd (Japan) SWOT Analysis
2.19.4 Takeda Pharmaceutical Company Ltd (Japan) Product and Services
2.19.5 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.20 RedHill Biopharma Ltd. (Israel)
2.20.1 RedHill Biopharma Ltd. (Israel) Details
2.20.2 RedHill Biopharma Ltd. (Israel) Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 RedHill Biopharma Ltd. (Israel) SWOT Analysis
2.20.4 RedHill Biopharma Ltd. (Israel) Product and Services
2.20.5 RedHill Biopharma Ltd. (Israel) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.21 Lexicon Pharmaceuticals, Inc. (U.S.)
2.21.1 Lexicon Pharmaceuticals, Inc. (U.S.) Details
2.21.2 Lexicon Pharmaceuticals, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Lexicon Pharmaceuticals, Inc. (U.S.) SWOT Analysis
2.21.4 Lexicon Pharmaceuticals, Inc. (U.S.) Product and Services
2.21.5 Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.22 Innovate Biopharmaceuticals (U.S.)
2.22.1 Innovate Biopharmaceuticals (U.S.) Details
2.22.2 Innovate Biopharmaceuticals (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Innovate Biopharmaceuticals (U.S.) SWOT Analysis
2.22.4 Innovate Biopharmaceuticals (U.S.) Product and Services
2.22.5 Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global IBS Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 IBS Treatment Players Market Share
3.2.2 Top 10 IBS Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global IBS Treatment Revenue and Market Share by Regions
4.2 North America IBS Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe IBS Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific IBS Treatment Revenue and Growth Rate (2015-2020)
4.5 South America IBS Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa IBS Treatment Revenue and Growth Rate (2015-2020)
5 North America IBS Treatment Revenue by Countries
5.1 North America IBS Treatment Revenue by Countries (2015-2020)
5.2 USA IBS Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada IBS Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico IBS Treatment Revenue and Growth Rate (2015-2020)
6 Europe IBS Treatment Revenue by Countries
6.1 Europe IBS Treatment Revenue by Countries (2015-2020)
6.2 Germany IBS Treatment Revenue and Growth Rate (2015-2020)
6.3 UK IBS Treatment Revenue and Growth Rate (2015-2020)
6.4 France IBS Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia IBS Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy IBS Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific IBS Treatment Revenue by Countries
7.1 Asia-Pacific IBS Treatment Revenue by Countries (2015-2020)
7.2 China IBS Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan IBS Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea IBS Treatment Revenue and Growth Rate (2015-2020)
7.5 India IBS Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia IBS Treatment Revenue and Growth Rate (2015-2020)
8 South America IBS Treatment Revenue by Countries
8.1 South America IBS Treatment Revenue by Countries (2015-2020)
8.2 Brazil IBS Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina IBS Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue IBS Treatment by Countries
9.1 Middle East & Africa IBS Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia IBS Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE IBS Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt IBS Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa IBS Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global IBS Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global IBS Treatment Market Forecast by Type (2019-2024)
10.3 IBS-D Revenue Growth Rate (2015-2025)
10.4 IBS-C Revenue Growth Rate (2015-2025)
10.5 IBS-M Revenue Growth Rate (2015-2025)
11 Global IBS Treatment Market Segment by Application
11.1 Global IBS Treatment Revenue Market Share by Application (2015-2020)
11.2 IBS Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Research Laboratories Revenue Growth (2015-2020)
12 Global IBS Treatment Market Size Forecast (2021-2025)
12.1 Global IBS Treatment Market Size Forecast (2021-2025)
12.2 Global IBS Treatment Market Forecast by Regions (2021-2025)
12.3 North America IBS Treatment Revenue Market Forecast (2021-2025)
12.4 Europe IBS Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific IBS Treatment Revenue Market Forecast (2021-2025)
12.6 South America IBS Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa IBS Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global IBS Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of IBS Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global IBS Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market IBS Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Allergan Plc (Ireland) Corporate Information, Location and Competitors
Table 6. Allergan Plc (Ireland) IBS Treatment Major Business
Table 7. Allergan Plc (Ireland) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Allergan Plc (Ireland) SWOT Analysis
Table 9. Allergan Plc (Ireland) IBS Treatment Product and Solutions
Table 10. Allergan Plc (Ireland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Ardelyx, Inc. (U.S.) Corporate Information, Location and Competitors
Table 12. Ardelyx, Inc. (U.S.) IBS Treatment Major Business
Table 13. Ardelyx, Inc. (U.S.) IBS Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Ardelyx, Inc. (U.S.) SWOT Analysis
Table 15. Ardelyx, Inc. (U.S.) IBS Treatment Product and Solutions
Table 16. Ardelyx, Inc. (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astellas Pharma Inc. (Japan) Corporate Information, Location and Competitors
Table 18. Astellas Pharma Inc. (Japan) IBS Treatment Major Business
Table 19. Astellas Pharma Inc. (Japan) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Astellas Pharma Inc. (Japan) SWOT Analysis
Table 21. Astellas Pharma Inc. (Japan) IBS Treatment Product and Solutions
Table 22. Astellas Pharma Inc. (Japan) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sucampo Pharmaceuticals (U.S.) Corporate Information, Location and Competitors
Table 24. Sucampo Pharmaceuticals (U.S.) IBS Treatment Major Business
Table 25. Sucampo Pharmaceuticals (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Sucampo Pharmaceuticals (U.S.) SWOT Analysis
Table 27. Sucampo Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 28. Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Synergy Pharmaceuticals, Inc. (U.S.) Corporate Information, Location and Competitors
Table 30. Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Major Business
Table 31. Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Synergy Pharmaceuticals, Inc. (U.S.) SWOT Analysis
Table 33. Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Product and Solutions
Table 34. Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Ironwood Pharmaceuticals, Inc. (U.S.) Corporate Information, Location and Competitors
Table 36. Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Major Business
Table 37. Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Ironwood Pharmaceuticals, Inc. (U.S.) SWOT Analysis
Table 39. Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Product and Solutions
Table 40. Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sebela Pharmaceuticals (Ireland) Corporate Information, Location and Competitors
Table 42. Sebela Pharmaceuticals (Ireland) IBS Treatment Major Business
Table 43. Sebela Pharmaceuticals (Ireland) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Sebela Pharmaceuticals (Ireland) SWOT Analysis
Table 45. Sebela Pharmaceuticals (Ireland) IBS Treatment Product and Solutions
Table 46. Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Abbott Laboratories (U.S.) Corporate Information, Location and Competitors
Table 48. Abbott Laboratories (U.S.) IBS Treatment Major Business
Table 49. Abbott Laboratories (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Abbott Laboratories (U.S.) SWOT Analysis
Table 51. Abbott Laboratories (U.S.) IBS Treatment Product and Solutions
Table 52. Abbott Laboratories (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bausch Health Corporate Information, Location and Competitors
Table 54. Bausch Health IBS Treatment Major Business
Table 55. Bausch Health IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Bausch Health SWOT Analysis
Table 57. Bausch Health IBS Treatment Product and Solutions
Table 58. Bausch Health IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Nestle (Switzerland) Corporate Information, Location and Competitors
Table 60. Nestle (Switzerland) IBS Treatment Major Business
Table 61. Nestle (Switzerland) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Nestle (Switzerland) SWOT Analysis
Table 63. Nestle (Switzerland) IBS Treatment Product and Solutions
Table 64. Nestle (Switzerland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Ipsen (France) Corporate Information, Location and Competitors
Table 66. Ipsen (France) IBS Treatment Major Business
Table 67. Ipsen (France) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Ipsen (France) SWOT Analysis
Table 69. Ipsen (France) IBS Treatment Product and Solutions
Table 70. Ipsen (France) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Synthetic Biologics, Inc. (U.S.) Corporate Information, Location and Competitors
Table 72. Synthetic Biologics, Inc. (U.S.) IBS Treatment Major Business
Table 73. Synthetic Biologics, Inc. (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Synthetic Biologics, Inc. (U.S.) SWOT Analysis
Table 75. Synthetic Biologics, Inc. (U.S.) IBS Treatment Product and Solutions
Table 76. Synthetic Biologics, Inc. (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Probi (Sweden) Corporate Information, Location and Competitors
Table 78. Probi (Sweden) IBS Treatment Major Business
Table 79. Probi (Sweden) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Probi (Sweden) SWOT Analysis
Table 81. Probi (Sweden) IBS Treatment Product and Solutions
Table 82. Probi (Sweden) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Pfizer Inc (U.S.) Corporate Information, Location and Competitors
Table 84. Pfizer Inc (U.S.) IBS Treatment Major Business
Table 85. Pfizer Inc (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Pfizer Inc (U.S.) SWOT Analysis
Table 87. Pfizer Inc (U.S.) IBS Treatment Product and Solutions
Table 88. Pfizer Inc (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Novartis AG (Switzerland) Corporate Information, Location and Competitors
Table 90. Novartis AG (Switzerland) IBS Treatment Major Business
Table 91. Novartis AG (Switzerland) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Novartis AG (Switzerland) SWOT Analysis
Table 93. Novartis AG (Switzerland) IBS Treatment Product and Solutions
Table 94. Novartis AG (Switzerland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. AstraZeneca (U.K) Corporate Information, Location and Competitors
Table 96. AstraZeneca (U.K) IBS Treatment Major Business
Table 97. AstraZeneca (U.K) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 98. AstraZeneca (U.K) SWOT Analysis
Table 99. AstraZeneca (U.K) IBS Treatment Product and Solutions
Table 100. AstraZeneca (U.K) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Alfasigma USA, Inc. (Italy) Corporate Information, Location and Competitors
Table 102. Alfasigma USA, Inc. (Italy) IBS Treatment Major Business
Table 103. Alfasigma USA, Inc. (Italy) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 104. Alfasigma USA, Inc. (Italy) SWOT Analysis
Table 105. Alfasigma USA, Inc. (Italy) IBS Treatment Product and Solutions
Table 106. Alfasigma USA, Inc. (Italy) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Protagonist Therapeutics Inc. (U.S.) IBS Treatment Type and Application
Table 108. Protagonist Therapeutics Inc. (U.S.) IBS Treatment Major Business
Table 109. Protagonist Therapeutics Inc. (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 110. Protagonist Therapeutics Inc. (U.S.) SWOT Analysis
Table 111. Protagonist Therapeutics Inc. (U.S.) IBS Treatment Product and Solutions
Table 112. Protagonist Therapeutics Inc. (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Takeda Pharmaceutical Company Ltd (Japan) Corporate Information, Location and Competitors
Table 114. Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Major Business
Table 115. Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 116. Takeda Pharmaceutical Company Ltd (Japan) SWOT Analysis
Table 117. Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Product and Solutions
Table 118. Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. RedHill Biopharma Ltd. (Israel) Corporate Information, Location and Competitors
Table 120. RedHill Biopharma Ltd. (Israel) IBS Treatment Major Business
Table 121. RedHill Biopharma Ltd. (Israel) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 122. RedHill Biopharma Ltd. (Israel) SWOT Analysis
Table 123. RedHill Biopharma Ltd. (Israel) IBS Treatment Product and Solutions
Table 124. RedHill Biopharma Ltd. (Israel) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Lexicon Pharmaceuticals, Inc. (U.S.) Corporate Information, Location and Competitors
Table 126. Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Major Business
Table 127. Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 128. Lexicon Pharmaceuticals, Inc. (U.S.) SWOT Analysis
Table 129. Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Product and Solutions
Table 130. Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Innovate Biopharmaceuticals (U.S.) Corporate Information, Location and Competitors
Table 132. Innovate Biopharmaceuticals (U.S.) IBS Treatment Major Business
Table 133. Innovate Biopharmaceuticals (U.S.) IBS Treatment Total Revenue (USD Million) (2017-2018)
Table 134. Innovate Biopharmaceuticals (U.S.) SWOT Analysis
Table 135. Innovate Biopharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 136. Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Global IBS Treatment Revenue (Million USD) by Players (2015-2020)
Table 138. Global IBS Treatment Revenue Share by Players (2015-2020)
Table 139. Global IBS Treatment Revenue (Million USD) by Regions (2015-2020)
Table 140. Global IBS Treatment Revenue Market Share by Regions (2015-2020)
Table 141. North America IBS Treatment Revenue by Countries (2015-2020)
Table 142. North America IBS Treatment Revenue Market Share by Countries (2015-2020)
Table 143. Europe IBS Treatment Revenue (Million USD) by Countries (2015-2020)
Table 144. Asia-Pacific IBS Treatment Revenue (Million USD) by Countries (2015-2020)
Table 145. South America IBS Treatment Revenue by Countries (2015-2020)
Table 146. South America IBS Treatment Revenue Market Share by Countries (2015-2020)
Table 147. Middle East and Africa IBS Treatment Revenue (Million USD) by Countries (2015-2020)
Table 148. Middle East and Africa IBS Treatment Revenue Market Share by Countries (2015-2020)
Table 149. Global IBS Treatment Revenue (Million USD) by Type (2015-2020)
Table 150. Global IBS Treatment Revenue Share by Type (2015-2020)
Table 151. Global IBS Treatment Revenue Forecast by Type (2021-2025)
Table 152. Global IBS Treatment Revenue by Application (2015-2020)
Table 153. Global IBS Treatment Revenue Share by Application (2015-2020)
Table 154. Global IBS Treatment Revenue Forecast by Application (2021-2025)
Table 155. Global IBS Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. IBS Treatment Picture
Figure 2. Global IBS Treatment Revenue Market Share by Type in 2019
Figure 3. IBS-D Picture
Figure 4. IBS-C Picture
Figure 5. IBS-M Picture
Figure 6. IBS Treatment Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Research Laboratories Picture
Figure 10. Global IBS Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America IBS Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe IBS Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific IBS Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America IBS Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa IBS Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global IBS Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global IBS Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players IBS Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players IBS Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global IBS Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global IBS Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global IBS Treatment Revenue Market Share by Regions in 2018
Figure 24. North America IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America IBS Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America IBS Treatment Revenue Market Share by Countries in 2019
Figure 31. USA IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe IBS Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe IBS Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific IBS Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific IBS Treatment Revenue Market Share by Countries in 2019
Figure 43. China IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America IBS Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America IBS Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa IBS Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa IBS Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa IBS Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global IBS Treatment Revenue Share by Type (2015-2020)
Figure 59. Global IBS Treatment Revenue Share by Type in 2019
Figure 60. Global IBS Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global IBS-D Revenue Growth Rate (2015-2020)
Figure 62. Global IBS-C Revenue Growth Rate (2015-2020)
Figure 63. Global IBS-M Revenue Growth Rate (2015-2020)
Figure 64. Global IBS Treatment Revenue Share by Application (2015-2020)
Figure 65. Global IBS Treatment Revenue Share by Application in 2019
Figure 66. Global IBS Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Research Laboratories Revenue Growth Rate (2015-2020)
Figure 70. Global IBS Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global IBS Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global IBS Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America IBS Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe IBS Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific IBS Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America IBS Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa IBS Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
交流電場腫瘍治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Alternating Electric Field Tumor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Al…- 胃炎治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Gastritis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gastritis Treatment marke…
- 眼瞼炎治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Blepharitis Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- HIV診断及び治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global HIV Diagnosis & Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HIV Diagnosis & Tre…
- 口臭治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Halitosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.1% in the forecast period of 2020 to 2025 and will expected to reach USD 14050 million by 2025, from USD 9564.6 million in 2019. The Halitosis Treatm…